Conducting field visits and surveys to gain a clear understanding of the situation, soliciting enterprises’ needs to promote development—Shi Yinfeng, Deputy Secretary of the Daxing District Party Committee, paid a visit to Minhai for research and guidance.

Release date:

2022-07-12

Author:

Source:


Abstract

Conducting field visits and surveys to gain a clear understanding of the situation, soliciting enterprises’ needs to promote development—Shi Yinfeng, Deputy Secretary of the Daxing District Party Committee, paid a visit to Minhai for research and guidance. On the afternoon of July 6, 2022, Shi Yinfeng, accompanied by Ma Yanzhu from the District Industrial Promotion Center and Zhang Long, General Manager of the Biopharmaceutical Base Company, led a delegation to Minhai Bio for an inspection and guidance session. The company’s General Manager Zheng Haifa, Executive Deputy General Manager Liu Jiankai, Production Deputy General Manager Nie Xiaoqi, and other relevant leaders were present to receive and accompany the group. At the briefing, General Manager Zheng first extended a warm welcome on behalf of the company’s leadership to Secretary Shi and his delegation. He then briefed the officials on the company’s development journey and recent…

On the afternoon of July 6, 2022, Shi Yinfeng, Deputy Secretary of the Daxing District Party Committee, accompanied by Ma Yanzhu from the District Industrial Promotion Center and Zhang Long, General Manager of the Biopharmaceutical Base Company, paid a visit to Minhai Bio for research and guidance. The company’s General Manager Zheng Haifa, Executive Deputy General Manager Liu Jiankai, Production Deputy General Manager Nie Xiaoqi, and other relevant leaders were present to receive the delegation.

 

 

At the research meeting, Company President Zheng first extended a warm welcome on behalf of the company’s leadership to Secretary Shi and his delegation. He then briefed the leaders on the company’s development journey, its major achievements over the past few years, its future development plans and strategic positioning, and placed particular emphasis on the progress of planning and construction for the new international‑standard vaccine industrial base. Secretary Shi expressed full appreciation for Minhai Bio’s development and encouraged the company to leverage its product portfolio to continue contributing to the pharmaceutical industry. He also inquired about the challenges encountered during the construction of the new international‑standard vaccine industrial base and pledged to coordinate with relevant departments after the meeting to provide support and assistance.

 

      

Following the conclusion of the symposium, Zheng Haifa, General Manager of the company, stated that Minhai Bio’s achievements have been made possible thanks to the strong support and favorable conditions provided over the years by the Daxing District Government and the Biomedical Base. He added that, moving forward, the company will continue to innovate, strengthen its core competitiveness, and translate its corporate culture—“Creating Better Vaccines to Serve Human Health”—and its ambitious vision into concrete actions, thereby contributing to the development of the biomedical industry in Daxing District.

 

 

 

Reading  296
 
 
Write your message.

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09